FDA Goes Ahead With Approval of Sufentanil Despite Controversy

The FDA’s approval of sufentanil, a highly potent opioid for severe acute pain in adults in certified medically supervised healthcare settings, causes controversy with claims that the vote was rigged.
FDA Approvals

Source link